Jyothy Labs Capital Structure Change
Jyothy Labs' board approved a Rs 147 Crore share buyback via tender offer at Rs 215 per share. The record date is November 11, 2026.
- Value
- ₹147.0 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements with these filters
Jyothy Labs' board approved a Rs 147 Crore share buyback via tender offer at Rs 215 per share. The record date is November 11, 2026.
Q2 EBITDA margin collapsed to 2.5% (16.1% last year) on a 34.8% gross margin. Management gave no numeric guidance and made H2 recovery conditional on commodity stability.
Jyothy Labs posted Q2 FY27 revenue of ₹760 crore and PAT of ₹10.6 crore. H1 FY27 revenue reached ₹1,533 crore with PAT of ₹58.2 crore amid margin pressure.
Q2 FY27 revenue rose 3.3% to ₹760 Cr, but operating EBITDA margin fell to 2.5% and PAT dropped 87.9% to ₹10.6 Cr on raw-material and packaging inflation.
Jyothy Labs Ltd reported revenue from operations of ₹760 Cr (+3.2% YoY) and net profit of ₹10.6 Cr (-87.9% YoY) for Q2 FY27.
Jyothy Labs intimated that its board meets on November 4, 2026 to consider a proposal for buyback of fully paid-up equity shares. Trading window stays closed until 48 hours after the outcome is disclosed.
Jyothy Labs filed its quarterly shareholding pattern. It disclosed an inter-se gift of shares within the promoter group, adding family trusts to the promoter group category.
Jyothy Labs has scheduled its Board of Directors meeting for November 4, 2026. The agenda includes approval of un-audited financial results for Q1 and H1 2026.